CJC-1295 without DAC + Ipamorelin Blend

The CJC-1295 without DAC + Ipamorelin Blend is a dual-peptide lyophilized research formulation combining a Growth Hormone–Releasing Hormone (GHRH) analogue and a Growth Hormone–Releasing Peptide (GHRP). By pairing these two mechanistically distinct compounds, the blend provides a model for investigating complementary pathways of growth hormone (GH) regulation — specifically, both GHRH receptor–mediated and ghrelin receptor (GHSR)–mediated signalling — within a single formulation. Each vial contains 5 mg CJC-1295 without DAC and 5 mg Ipamorelin, confirmed at a purity of ≥99% by High-Performance Liquid Chromatography (HPLC).

Blend composition

• CJC-1295 without DAC (5 mg): A GHRH analogue investigated for its role in supporting natural, pulsatile GH release through GHRH receptor activation.
• Ipamorelin (5 mg): A selective GHRP studied for activation of ghrelin receptors (GHSR), and referenced in the literature for its comparatively limited influence on cortisol and prolactin pathways relative to earlier-generation GHRPs.

Research background

This combination has been investigated in the context of dual-pathway GH secretion, where simultaneous GHRH receptor and GHSR activation has been studied for potential additive or synergistic effects on GH pulse amplitude. The blend has been referenced in biochemical and endocrinological research focused on GHRH and GHSR signalling interactions, as well as in broader in-vitro studies examining metabolic regulation and GH stimulation protocols. Each component has an established independent research profile, and their combination is used to model the coordinated receptor-level events that govern somatotroph activity.

Reconstitution & handling

This product is supplied as a lyophilized powder and should be reconstituted with an appropriate volume of bacteriostatic water (BAC water) prior to use. Add the BAC water slowly to the vial, then gently swirl — do not shake — until the powder is fully dissolved. All handling should be carried out under sterile laboratory conditions using appropriate aseptic technique.

Storage & stability

The lyophilized product should be stored refrigerated, protected from light and moisture. Once reconstituted, the solution should be kept refrigerated and used within a short timeframe in accordance with standard laboratory practice for peptide solutions.

A batch-specific Certificate of Analysis (CoA) accompanies every order, confirming identity and purity.